NEW YORK (GenomeWeb) – The nation's top lab industry group is mulling legal strategies as part of its overall push to thwart regulation of laboratory-developed tests (LDTs) by the US Food and Drug Administration.

The American Clinical Laboratory Association announced today that it has retained Solicitor General Paul Clement, a partner at Bancroft PLLC, and Laurence Tribe, constitutional law professor at Harvard University, for "representation on matters relating to the FDA's recently issued draft guidance to regulate LDTs as medical devices."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.